The genetic basis and cell of origin of mixed phenotype acute leukaemia.
Alexander, TB
Gu, Z
Iacobucci, I
Dickerson, K
Choi, JK
Xu, B
Payne-Turner, D
Yoshihara, H
Loh, ML
Horan, J
Buldini, B
Basso, G
Elitzur, S
de Haas, V
Zwaan, CM
Yeoh, A
Reinhardt, D
Tomizawa, D
Kiyokawa, N
Lammens, T
De Moerloose, B
Catchpoole, D
Hori, H
Moorman, A
Moore, AS
Hrusak, O
Meshinchi, S
Orgel, E
Devidas, M
Borowitz, M
Wood, B
Heerema, NA
Carrol, A
Yang, Y-L
Smith, MA
Davidsen, TM
Hermida, LC
Gesuwan, P
Marra, MA
Ma, Y
Mungall, AJ
Moore, RA
Jones, SJM
Valentine, M
Janke, LJ
Rubnitz, JE
Pui, C-H
Ding, L
Liu, Y
Zhang, J
Nichols, KE
Downing, JR
Cao, X
Shi, L
Pounds, S
Newman, S
Pei, D
Guidry Auvil, JM
Gerhard, DS
Hunger, SP
Inaba, H
Mullighan, CG
Hori, H
Moorman, A
Moore, AS
Hrusak, O
Meshinchi, S
Orgel, E
Devidas, M
Borowitz, M
Wood, B
Heerema, NA
Carrol, A
Yang, Y-L
Smith, MA
Davidsen, TM
Hermida, LC
Gesuwan, P
Marra, MA
Ma, Y
Mungall, AJ
Moore, RA
Jones, SJM
Valentine, M
Janke, LJ
Rubnitz, JE
Pui, C-H
Ding, L
Liu, Y
Zhang, J
Nichols, KE
Downing, JR
Cao, X
Shi, L
Pounds, S
Newman, S
Pei, D
Guidry Auvil, JM
Gerhard, DS
Hunger, SP
Inaba, H
Mullighan, CG
- Publisher:
- Springer Science and Business Media LLC
- Publication Type:
- Journal Article
- Citation:
- Nature, 2018, 562, (7727), pp. 373-379
- Issue Date:
- 2018-10
Closed Access
| Filename | Description | Size | |||
|---|---|---|---|---|---|
| s41586-018-0436-0.pdf | Published version | 15.14 MB |
Copyright Clearance Process
- Recently Added
- In Progress
- Closed Access
This item is closed access and not available.
Mixed phenotype acute leukaemia (MPAL) is a high-risk subtype of leukaemia with myeloid and lymphoid features, limited genetic characterization, and a lack of consensus regarding appropriate therapy. Here we show that the two principal subtypes of MPAL, T/myeloid (T/M) and B/myeloid (B/M), are genetically distinct. Rearrangement of ZNF384 is common in B/M MPAL, and biallelic WT1 alterations are common in T/M MPAL, which shares genomic features with early T-cell precursor acute lymphoblastic leukaemia. We show that the intratumoral immunophenotypic heterogeneity characteristic of MPAL is independent of somatic genetic variation, that founding lesions arise in primitive haematopoietic progenitors, and that individual phenotypic subpopulations can reconstitute the immunophenotypic diversity in vivo. These findings indicate that the cell of origin and founding lesions, rather than an accumulation of distinct genomic alterations, prime tumour cells for lineage promiscuity. Moreover, these findings position MPAL in the spectrum of immature leukaemias and provide a genetically informed framework for future clinical trials of potential treatments for MPAL.
Please use this identifier to cite or link to this item: